Lineage Cell Therapeutics (LCTX) Stock Price
$1.25 6.8%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Lineage Cell Therapeutics, AI stock picks, stock alerts and much more.
LCTX AI Stock Analysis
AI stock analysis for LCTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Lineage Cell Therapeutics (LCTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Lineage Cell Therapeutics (LCTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Lineage Cell Therapeutics (LCTX), currently trading at $1.25, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About LCTX
-
Lineage Cell Therapeutics, Inc.
-
Symbol
LCTX
-
Market
AMEX
-
Industry
Biotechnology
-
Market Cap
285.4M
Similar Stocks
 |
Cybin CYBN |
$7.45 2.8% |
4 |
 |
Calidi Biotherapeutics CLDI |
$1.7 9% |
5 |
 |
NovaBay Pharmaceuticals NBY |
$0.899 0.8% |
4 |
News
LCTX Alternative Data
Web Traffic
Lineage Cell Therapeutics receives an estimated 8198 monthly visitors to lineagecell.com.
-
Web Traffic
8198
-
Change from Previous Month
64.9%
-
3 Month Change
117.7%
-
YoY Change
117.7%
Reddit Mentions
Lineage Cell Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Twitter Followers
Lineage Cell Therapeutics has 2,308 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
2308
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
2.7%
Facebook Engagement
Lineage Cell Therapeutics has engaged 16 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
16
-
Daily Change
14.3%
-
1 Month Change
0%
-
3 Month Change
45.5%
LinkedIn Followers
5,972 are following Lineage Cell Therapeutics on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
5972
-
Daily Change
0.1%
-
1 Month Change
1.8%
-
3 Month Change
5%
Job Postings
Lineage Cell Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Lineage Cell Therapeutics has 31 employees, down by -3.1% over the last month.
-
LinkedIn Employees
31
-
Daily Change
0%
-
1 Month Change
3.1%
-
3 Month Change
8.8%
News Mentions
Lineage Cell Therapeutics was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LCTX Financials
LCTX Key Metrics
-
Total Revenue
$2.9M
-
Net Income
-$3.3M
-
Earnings per Share
-$0.0163
-
Free cash flow
-$6.7M
-
EBITDA
-$5M
-
EBITDA Ratio
-1.72908
-
Total Assets
$113.2M
LCTX 2-year Revenue & Income
LCTX 2-year Free Cash Flow
LCTX Technicals
LCTX SMA
LCTX RSI
FAQ
What's the current price of Lineage Cell Therapeutics (LCTX) Stock?
The price of an Lineage Cell Therapeutics (LCTX) share is $1.25.
What's the market cap of Lineage Cell Therapeutics?
The current market cap of Lineage Cell Therapeutics is 285.4M.
Should I buy or sell LCTX?
Lineage Cell Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Lineage Cell Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Lineage Cell Therapeutics a good investment?
The current analysis of Lineage Cell Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Lineage Cell Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Lineage Cell Therapeutics (LCTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Lineage Cell Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Lineage Cell Therapeutics (LCTX) that investors often compare it to?
Lineage Cell Therapeutics (LCTX) is often compared to similar stocks such as Cybin, Calidi Biotherapeutics and NovaBay Pharmaceuticals.
What is the forecast for Lineage Cell Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Lineage Cell Therapeutics' stock price to be around $1.3 in 2026. Starting from the current price of $1.25, this represents a 4.2% change in price, indicating a neutral outlook for the stock.
How to buy Lineage Cell Therapeutics (LCTX) Stock?
Lineage Cell Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Lineage Cell Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.